Replimune Group Inc
NASDAQ:REPL
During the last 3 months Replimune Group Inc insiders have not bought any shares, and sold 144.3k USD worth of shares. The stock price has dropped by 11% over this period (open performance analysis).
The last transaction was made on
Dec 9, 2025
by
Dhingra Kapil
, who
sold
33k USD
worth of 
REPL shares.
During the last 3 months Replimune Group Inc insiders have not bought any shares, and sold 144.3k USD worth of shares. The stock price has dropped by 11% over this period (open performance analysis).
The last transaction was made on
Dec 9, 2025
by
Dhingra Kapil
, who
sold
33k USD
worth of REPL shares.
Replimune Group Inc
Glance View
Replimune Group, Inc. is a clinical-stage biotechnology company, which engages in the development of oncolytic immunotherapy product candidates through immulytic platform. The company is headquartered in Woburn, Massachusetts and currently employs 152 full-time employees. The company went IPO on 2018-07-20. The firm is engaged in the field of oncolytic immunotherapy to treat the cancer patients. The firm applies its Immulytic platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The firm is focused on developing a pipeline of oncolytic immunotherapy product candidates to provide clinical benefits to cancer patients. Its product candidates include RP1 (vusolimogene oderparepvec), RP2, and RP3. The firm is focused on Phase 2 clinical trials with its lead product candidate, RP1, in approximately 240 patients with a range of solid tumors.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
